Overview

Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
0
Participant gender:
All
Summary
Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hormozgan University of Medical Sciences
Treatments:
Mometasone Furoate
Criteria
Inclusion Criteria:

- • Children who were between 2 to 6 years old

- Definite diagnosis of OME with symptoms and examination

Exclusion Criteria:

- • Currently were using corticosteroids or prophylactic monteleukast

- Chronic pulmonary or cardiac diseases or immune deficiency

- Allergic rhinitis

- Hypersensitivity to monteleukast or corticosteroids

- Avoidance of parents to fill the written informed consent